4/23/2024  5:35:01 PM Chg. +0.920 Volume Bid4/23/2024 Ask5:35:01 PM Market Capitalization Dividend Y. P/E Ratio
39.900EUR +2.36% 801,792
Turnover: 31.96 mill.
-Bid Size: - -Ask Size: - 11.67 bill.EUR 2.99% 23.39

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Helen Giza
Management board
Martin Fischer, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, Craig Cordola
Supervisory board
Michael Sen, Stefanie Balling, Sara Hennicken, Shervin J. Korangy, Dr. Marcus Kuhnert, Gregory Sorensen, M.D., Pascale Witz, Ralf Erkens, Beate Haßdenteufel, Regina Karsch, Frank Michael Prescher, Dr. Manuela Stauss-Grabo
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 44.95%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49 (0) 6172 609-2525
IR Fax: +49 (0) 6172 609-2301
IR e-mail: ir@fmc-ag.com

Company calendar

CW 19 | 5/7/2024 Interim Report 1st Quarter/3 Months
CW 20 | 5/16/2024 General Shareholder Meeting
CW 20 | 5/17/2024 Ex-Dividend
CW 21 | 5/20/2024 Record Date
CW 21 | 5/22/2024 Dividend Payment
 

Main Shareholders

Institutional investors
 
61.00%
Else-Kröner-Fresenius-Stiftung
 
27.00%
Retail holdings
 
8.00%
Not identified
 
4.00%